PTPN11 and histiocytic sarcoma: Voruz et al. reported a case of a 66-year-old man with multifocal HS harboring PTPN11 mutations who was treated with trametinib after failure of intensive chemotherapy, achieving an excellent partial remission after 2 months of treatment [76].